Abbvie Inc
NYSE: ABBV
$207.76
-$3.72 (-1.8%)
Closing Price on March 4, 2025
ABBV Articles
Rotating from overbought and crowded momentum stocks makes sense now. From a total return standpoint, dividend-paying large-cap pharmaceutical stocks may be one of the best ideas for 2021.
Published:
Wednesday's top analyst upgrades and downgrades included Baidu, BigCommerce, Boeing, Ciena, Deere, GoodRx, Kohl's, ONEOK, Tesla and Walmart.
Published:
Some rather significant changes were made in the Berkshire Hathaway equity portfolio during the third quarter.
Published:
Tuesday's top analyst upgrades and downgrades included AbbVie, Beyond Meat, Biogen, Eli Lilly, Levi Strauss, Nvidia, Pfizer, Plug Power, Raytheon, Square and Wayfair.
Published:
Last Updated:
Here are six health care stocks that appear to be specific winners based on a mixed Congress, regardless of which presidential candidate is declared the winner.
Published:
Monday's top analyst upgrades and downgrades included AbbVie, Alibaba, Archer Daniels Midland, Best Buy, Intel, Nikola, Peloton Interactive, SAP, Under Armour and Wynn Resorts.
Published:
Health care is one sector that continues to draw a ton of fund manager interest, and with good reason. These five dividend-paying health care stocks are all favored by large-cap portfolio managers.
Published:
These five high-conviction medical technology health care ideas from Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well during the fourth...
Published:
Tuesday's top analyst upgrades and downgrades included AbbVie, CSX, Dominion Energy, JPMorgan, NXP Semiconductors, ONEOK, Pfizer, Square, United Parcel Service and WPX Energy.
Published:
These five Dividend Aristocrats have sizable upside to the Wall Street targets and pay at least 4%. In a market that is very long in the tooth, they make sense now.
Published:
A hot equity market from some popular stocks has overshadowed the steady payouts from many, less spectacular, but reliable companies. Here are eight overlooked stocks.
Published:
These five dividend-paying large-cap pharmaceutical stocks look like outstanding ideas for nervous investors looking for income and a degree of safety. They have come way in from their 52-week...
Published:
Monday's top analyst upgrades and downgrades included AbbVie, DuPont, Etsy, Expedia, Exxon Mobile, Kansas City Southern, Merck, Microsoft, Pinterest, Qualcomm, Visa and Yum! Brands.
Published:
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Published:
Tuesday's top analyst upgrades and downgrades included AbbVie, Ambarella, Apple, DocuSign, Home Depot, Lowe's, Micron Technology, Nike, PG&E, ViacomCBS, YETI and Yext.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.